Global Instrumentation and University of Rochester to Collaborate around the Development of Technologies used by the Telemetric and Holter ECG Warehouse (THEW) Initiative 

Global Instrumentation joins the URMC/FDA initiative to enable secured WEB environment technologies for sharing health information from the THEW.

Manlius, NY , 03-Dec-2008 – Global Instrumentation has signed an agreement with the University of Rochester supporting the activities of the THEW. Global Instrumentation has provided supporting technologies to develop the THEW software and to enable worldwide access to clinical and electrocardiographic information using advanced security and encryption algorithms.

The THEW is a not-for-profit organization developed to advance the field of cardiac safety by distributing tools, data and expertise to academic and private organizations. The THEW hosts large databases including millions of ECG tracings and health information from clinical and drug-safety trials. Amongst the list of tools provided by the THEW, the Client Application allows to review and distribute the electrocardiographic and clinical information. This software is built from key components provided by Global Instrumentation enabling secured remote access over the internet. 

The THEW software includes plug-in application programming interface (API) for the design and validation of analytic methods.  Through this plug-in API, software review and analysis add-ons can be created by third party software developers and used seamlessly within the THEW software.

Dr. Jean-Philippe Couderc PhD, Director of the THEW commented: “The agreement with Global Instrumentation is helping the THEW to distribute worldwide the information contained in its large database of ECGs and clinical data. These technologies will ensure both a fully compliant and most secured environment for the THEW members to develop their ECG technologies independently.” Dr. Couderc added, “Global Instruments is one of the pioneering companies providing unique and leading technologies to our initiative.”   

Jim DeMaso president of Global Instrumentation commented: “Integrating our web-based distributed application technology into the THEW has provided an excellent show case of the advantages of a thick-client web services based solution. Our technology allows for multiple users to access the THEW  ECG databases using an internet connection. This same key technology is also used within the Global M12A Enterprise based Holter system which is designed for Clinical Trials, Holter Scanning services or applications that have distributed sites connected via the internet.”   

Independent cardiac researchers can also access this API technology through the new Global Instrumentation M12 Holter system research toolkit product.  The M12 Holter system research toolkit provides ‘stand alone’ ambulatory ECG data recorders and analysis software for use by Cardiac researchers worldwide. Global Instrumentation develops and markets the highest performance and most cost effective state-of-the-art cardiac monitoring systems.  Global’s products utilize modular components that can be adapted for custom research applications.

About Global Instrumentation, LLC:

Global Instrumentation’s is a privately owned company with headquarters located in Manlius , New York and with operations in India and Florida .  Global Instrumentation develops, manufactures and distributes its ECG devices worldwide and thru OEM relationships. The company also provides design, manufacturing, and product support services to companies within the medical industries. The three principals of Global have over 80 years of experience developing medical products including Blood Pressure system, Electrocardiographs, Stress test system, Data management system and Holter technologies for various medical companies. Global Instrumentation is an FDA Registered manufacturer with certification for ISO13485 and CMDCAS. Global follows strict design control processes that meet the all the FDA and ISO design controls. Global current products include a complete line of Holter products consisting Ambulatory ECG recorders and Holter Analysis systems designed for standalone usage as well as enterprise web based usage. The company also has specific solutions for web-based data warehousing to support any clinical trial, scanning service or distributed processing centers. More information can be found at www.gimedical.com .

About THEW: The Telemetric and Holter ECG Warehouse (THEW) is a not-profit organization hosted at the University of Rochester (UR) Medical Center (NY). The THEW is a research platform for sharing data, tools and expertise for the development of ECG-related technologies. The THEW benefits from the scientific and technical heritage of the Heart Research Follow-UP program which has more than 20 years of research experience in quantitative analysis of ventricular repolarization involving animals, normal subjects, patients with genetic (Long QT Syndrome) and acquired cardiac disorders. Striving to advance the field of cardiac safety, the THEW initiative is developed under an agreement with the Food and Drug Administration for facilitating collaborative discussions between THEW members, and for leveraging resources to implement joint projects among FDA, UR , and other public and private stakeholders. The THEW is led by individuals from the UR , the Commissioner Office of the FDA, the Center for Drug Evaluation and Research, and the Center for Devices and Radiological Health. More information can be found at www.thew-project.org .